Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SOLARAZE
- 5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis
- Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp
- A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
- Effects of Topical Diclofenac on Tumor Metabolism
- A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)
- Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses
- Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
- Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head
Clinical trials list
click for details